MoneyWorks4Me

Sandu Pharmaceuticals informs about disclosure

04 Apr 2022 Evaluate

Pursuant to Regulation 30 and PART A pf Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, Sandu Pharmaceuticals has informed that it enclosed a copy of the letter being sent to the shareholders holding shares in physical mode in compliance with the SEBI Circular No. SEBI/MIRSD-RTAMB/P/CIR/2021/655 dated November 3,2021. The Company has informed the physical shareholders to furnish their PAN, KYC and nomination details to the Registrar and Transfer Agent of the Company- Link in time India.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1738.10
Dr. Reddys Labs. 1228.35
Cipla 1304.85
Lupin 1912.85
Zydus Lifesciences 1108.15
View more..